Literature DB >> 3833084

Psychometrics in aging and dementia: advances in geropsychological assessments.

W D Oswald, U M Fleischmann.   

Abstract

Description, explanation and prediction of changes occurring in old age, which are based on intervention, are outlined as a basic goal in gerontological research. Appropriate psychological assessment techniques are necessary to reach this goal. The Nuremberg Gerontopsychological Inventory (NAI) is introduced as a set of psychological measurements which enable reliable, valid and sensitive evaluation of intervention-induced changes in old age. Four independent assessment levels, i.e. standardized performance tests, observer-ratings, self-ratings and a personality rating are the core components of this inventory. All assessment techniques are adapted for elderly subjects. Standard scores are available for the age range 55-90 years. Interrelations between the applied independent assessment levels are reported and taken to link different aspects of intervention-induced changes. Measuring psychological performance thus gains practical significance, e.g. in terms of activities-of-daily-living. From 14 independent studies the drug sensitivity of the applied measurements is shown. Finally, some recommendations for future psychometrical research are given.

Entities:  

Mesh:

Year:  1985        PMID: 3833084     DOI: 10.1016/0167-4943(85)90037-8

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  10 in total

1.  Association of childhood traumatization and neuropsychiatric outcomes with altered plasma micro RNA-levels.

Authors:  Sandra Van der Auwera; Sabine Ameling; Katharina Wittfeld; Enrique d'Harcourt Rowold; Matthias Nauck; Henry Völzke; Karsten Suhre; Hani Najafi-Shoushtari; Jaicy Methew; Vimal Ramachandran; Robin Bülow; Uwe Völker; Hans J Grabe
Journal:  Neuropsychopharmacology       Date:  2019-07-08       Impact factor: 7.853

2.  Aversive and reinforcing opioid effects: a pharmacogenomic twin study.

Authors:  Martin S Angst; Laura C Lazzeroni; Nicholas G Phillips; David R Drover; Martha Tingle; Amrita Ray; Gary E Swan; J David Clark
Journal:  Anesthesiology       Date:  2012-07       Impact factor: 7.892

3.  Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial.

Authors:  Stefan J Teipel; Alexander Drzezga; Peter Bartenstein; Hans-Jürgen Möller; Markus Schwaiger; Harald Hampel
Journal:  Psychopharmacology (Berl)       Date:  2006-06-01       Impact factor: 4.530

4.  National context of healthcare, economy and religion, and the association between disability and depressive symptoms in older Europeans: results from the EURODEP concerted action.

Authors:  Arjan W Braam; Philippe Delespaul; Aartjan T F Beekman; Dorly J H Deeg; Karine Pérès; Michael Dewey; Sirkka-Liisa Kivelä; Brian A Lawlor; Hallgrímur Magnússon; Ingeborg Meller; Martin J Prince; Friedel M Reischies; Marc Roelands; Pedro Saz; Robert A Schoevers; Ingmar Skoog; Cesare Turrina; Ann Versporten; John R M Copeland
Journal:  Eur J Ageing       Date:  2004-11-11

5.  [Alzheimer's disease with secondary Parkinson's syndrome. Case report of a patient with dementia and Parkinson's syndrome after long-term occupational exposure to insecticides, herbicides, and pesticides].

Authors:  C Laske; H Wormstall; K Einsiedler; G Buchkremer
Journal:  Nervenarzt       Date:  2004-11       Impact factor: 1.214

6.  Functional disability and death wishes in older Europeans: results from the EURODEP concerted action.

Authors:  Madeleine Mellqvist Fässberg; Svante Östling; Arjan W Braam; Kristoffer Bäckman; John R M Copeland; Manfred Fichter; Sirkka-Liisa Kivelä; Brian A Lawlor; Antonio Lobo; Halggrimur Magnússon; Martin J Prince; Friedel M Reischies; Cesare Turrina; Kenneth Wilson; Ingmar Skoog; Margda Waern
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-20       Impact factor: 4.328

7.  Variability in the validity and reliability of outcome measures identified in a systematic review to assess treatment efficacy of cognitive enhancers for Alzheimer's Dementia.

Authors:  Charlene Soobiah; Mina Tadrous; Sandra Knowles; Erik Blondal; Huda M Ashoor; Marco Ghassemi; Paul A Khan; Joanne Ho; Andrea C Tricco; Sharon E Straus
Journal:  PLoS One       Date:  2019-04-18       Impact factor: 3.240

8.  Multifactorial intervention for hip and pelvic fracture patients with mild to moderate cognitive impairment: study protocol of a dual-centre randomised controlled trial (OF-CARE).

Authors:  Anja Dautel; Tobias Eckert; Michaela Gross; Klaus Hauer; Martina Schäufele; André Lacroix; Ingrid Hendlmeier; Bastian Abel; Rebekka Pomiersky; Julia Gugenhan; Gisela Büchele; Katrin C Reber; Clemens Becker; Klaus Pfeiffer
Journal:  BMC Geriatr       Date:  2019-04-30       Impact factor: 3.921

9.  A Biomarker for Alzheimer's Disease Based on Patterns of Regional Brain Atrophy.

Authors:  Stefan Frenzel; Katharina Wittfeld; Mohamad Habes; Johanna Klinger-König; Robin Bülow; Henry Völzke; Hans Jörgen Grabe
Journal:  Front Psychiatry       Date:  2020-01-14       Impact factor: 4.157

Review 10.  A Possible Association Between Executive Dysfunction and Frailty in Patients With Neurocognitive Disorders.

Authors:  Massimo Bartoli; Sara Palermo; Giuseppina Elena Cipriani; Martina Amanzio
Journal:  Front Psychol       Date:  2020-11-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.